Vadadustat for Anemia in Chronic Kidney Disease: Questions Remain Vadadustat for Anemia in Chronic Kidney Disease: Questions Remain
The HIF prolyl hydroxylase inhibitor shows efficacy in the treatment of anemia with chronic kidney disease, but in non-dialysis patients increased cardiovascular risks are observed.Medscape Medical News
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Nephrology News Source Type: news
More News: Anemia | Cardiology | Cardiovascular | Chronic Kidney Disease | Dialysis | Heart | Kidney Transplant | Kidney Transplantation | Transplant Surgery | Transplants | Urology & Nephrology